Cearvol Wave vs EarCentric EX2

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. The Wave's standout performance is in music streaming, where it scores a strong 4.1/5—a full 2.18 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside speech amplification. Speech performance is solid in quiet environments at 3.1/5, sitting 0.36 points above the category average. Speech in noise presents a more mixed picture: while the 2.0/5 score exceeds the category average by 0.56 points, it remains modest in absolute terms—typical of OTC devices without advanced noise management. Own-voice comfort scores 2.1/5, falling 0.41 points below average, which may be noticeable during extended wear. Feedback handling is solid at 3.8/5, though 0.74 points below the category average. The Cearvol Wave is best suited for budget-conscious consumers who want capable music streaming and adequate speech clarity in quieter settings. Those frequently in noisy environments or sensitive to own-voice quality may want to consider alternatives with stronger performance in those areas.

The EarCentric EX2 is a budget-priced prescription behind-the-ear hearing aid released in 2021, earning a C grade with a SoundScore of 2.7/5 in HearAdvisor's lab testing. At $218, it ranks #33 of 36 prescription hearing aids tested, placing it in the bottom 11% of its category. In our testing, the EX2 showed a significant split in performance. Feedback handling was excellent at 4.7/5, essentially matching the category average and demonstrating stable operation during movement. However, speech performance was notably limited, with both speech in quiet and speech in noise scoring 1.0/5—well below the category averages of 3.32 and 1.96 respectively. Music streaming scored 0.0/5, falling 2.64 points below the prescription category average of 2.64/5. Own-voice comfort scored 2.3/5, a mixed result that sits 0.45 points below the category average. The device uses a rechargeable battery, which adds convenience for daily use. Notably, tuning did not improve performance in our testing—the Initial and Tuned fit scores were identical at 2.7/5. Budget-conscious shoppers in this price range may want to compare alternatives. The RxEars Rxi scored 4.09/5 at a similar price point, while OTC options like the Audien Hearing Atom offer comparable or better sound performance at lower prices. The EX2 may suit users who prioritize feedback stability and rechargeable convenience over speech clarity, but its limited speech performance is a significant tradeoff.